EIGER GROUP INT INC has a total of 11 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are QURIENT CO LTD, STEHLIN FOUNDATION FOR CANCER and SHANGHAI HUILUN LIFE SCIENCE & TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 2 | |
#2 | Brazil | 1 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Hong Kong | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Pham Edward A | 8 |
#2 | Glenn Jeffrey S | 8 |
#3 | Jeffrey S Glenn | 2 |
#4 | Edward A Pham | 2 |
Publication | Filing date | Title |
---|---|---|
CN107922404A | Chloroquine and clemizole compound are used for the purposes for treating inflammation and cancer |